|
Powered by Cell Signaling Technology |
Site Information |
---|
FHRNDsIyEELQKHD SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 447802 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on FHIT: | |
Effects of modification on biological processes: | |
Induce interaction with: |
References | |
---|---|
Pichiorri F, et al. (2009) Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions. J Biol Chem 284, 1040-9
19004824 Curated Info |
|
Bianchi F, et al. (2006) FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells. Proc Natl Acad Sci U S A 103, 18981-6
17142325 Curated Info |
|
Semba S, et al. (2006) Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential. Oncogene 25, 2860-72
16407838 Curated Info |
|
Garrison PN, et al. (2005) Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms. Biochemistry 44, 6286-92
15835917 Curated Info |
|
Pekarsky Y, et al. (2004) Fhit is a physiological target of the protein kinase Src. Proc Natl Acad Sci U S A 101, 3775-9
15007172 Curated Info |